| Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction W Qin, T Yang, L Ho, Z Zhao, J Wang, L Chen, W Zhao, M Thiyagarajan, ... Journal of Biological Chemistry 281 (31), 21745-21754, 2006 | 764 | 2006 |
| Increased plasma levels of interleukin-1, interleukin-6 and α-1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain? F Licastro, S Pedrini, L Caputo, G Annoni, LJ Davis, C Ferri, V Casadei, ... Journal of neuroimmunology 103 (1), 97-102, 2000 | 497 | 2000 |
| Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer’s disease P Chatterjee, S Pedrini, E Stoops, K Goozee, VL Villemagne, PR Asih, ... Translational psychiatry 11 (1), 27, 2021 | 341 | 2021 |
| Modulation of statin-activated shedding of Alzheimer APP ectodomain by ROCK S Pedrini, TL Carter, G Prendergast, S Petanceska, ME Ehrlich, S Gandy PLoS medicine 2 (1), e18, 2005 | 221 | 2005 |
| ALS-linked mutant SOD1 damages mitochondria by promoting conformational changes in Bcl-2 S Pedrini, D Sau, S Guareschi, M Bogush, RH Brown Jr, N Naniche, A Kia, ... Human molecular genetics 19 (15), 2974-2986, 2010 | 178 | 2010 |
| Thiamine deficiency induces oxidative stress and exacerbates the plaque pathology in Alzheimer's mouse model SS Karuppagounder, H Xu, Q Shi, LH Chen, S Pedrini, D Pechman, ... Neurobiology of aging 30 (10), 1587-1600, 2009 | 167 | 2009 |
| Gene polymorphism affecting α1‐antichymotrypsin and interleukin‐1 plasma levels increases Alzheimer's disease risk F Licastro, S Pedrini, C Ferri, V Casadei, M Govoni, A Pession, FL Sciacca, ... Annals of neurology 48 (3), 388-391, 2000 | 159 | 2000 |
| Diagnostic and prognostic plasma biomarkers for preclinical Alzheimer's disease P Chatterjee, S Pedrini, NJ Ashton, M Tegg, K Goozee, AK Singh, ... Alzheimer's & Dementia 18 (6), 1141-1154, 2022 | 156 | 2022 |
| Alzheimer’s disease: a journey from amyloid peptides and oxidative stress, to biomarker technologies and disease prevention strategies—gains from AIBL and DIAN cohort studies RN Martins, V Villemagne, HR Sohrabi, P Chatterjee, TM Shah, G Verdile, ... Journal of Alzheimer's Disease 62 (3), 965-992, 2018 | 139 | 2018 |
| Plasma Aβ42/40 ratio, p‐tau181, GFAP, and NfL across the Alzheimer's disease continuum: a cross‐sectional and longitudinal study in the AIBL cohort P Chatterjee, S Pedrini, JD Doecke, R Thota, VL Villemagne, V Doré, ... Alzheimer's & Dementia 19 (4), 1117-1134, 2023 | 129 | 2023 |
| Potential of coconut oil and medium chain triglycerides in the prevention and treatment of Alzheimer’s disease P Chatterjee, M Fernando, B Fernando, CB Dias, T Shah, R Silva, ... Mechanisms of Ageing and Development 186, 111209, 2020 | 109 | 2020 |
| Atorvastatin‐induced activation of Alzheimer's α secretase is resistant to standard inhibitors of protein phosphorylation‐regulated ectodomain shedding S Parvathy, M Ehrlich, S Pedrini, N Diaz, L Refolo, JD Buxbaum, ... Journal of neurochemistry 90 (4), 1005-1010, 2004 | 91 | 2004 |
| A plasma protein classifier for predicting amyloid burden for preclinical Alzheimer’s disease NJ Ashton, AJ Nevado-Holgado, IS Barber, S Lynham, V Gupta, ... Science advances 5 (2), eaau7220, 2019 | 80 | 2019 |
| Physiological mouse brain Aβ levels are not related to the phosphorylation state of threonine-668 of Alzheimer's APP Y Sano, T Nakaya, S Pedrini, S Takeda, K Iijima-Ando, K Iijima, ... PloS one 1 (1), e51, 2006 | 78 | 2006 |
| AKT and CDK5/p35 mediate brain-derived neurotrophic factor induction of DARPP-32 in medium size spiny neurons in vitro A Bogush, S Pedrini, J Pelta-Heller, T Chan, Q Yang, Z Mao, E Sluzas, ... Journal of Biological Chemistry 282 (10), 7352-7359, 2007 | 73 | 2007 |
| Small peptides against the mutant SOD1/Bcl-2 toxic mitochondrial complex restore mitochondrial function and cell viability in mutant SOD1-mediated ALS W Tan, N Naniche, A Bogush, S Pedrini, D Trotti, P Pasinelli Journal of Neuroscience 33 (28), 11588-11598, 2013 | 68 | 2013 |
| Plasma neurofilament light chain and amyloid-β are associated with the kynurenine pathway metabolites in preclinical Alzheimer’s disease P Chatterjee, H Zetterberg, K Goozee, CK Lim, KR Jacobs, NJ Ashton, ... Journal of neuroinflammation 16, 1-12, 2019 | 59 | 2019 |
| Ultrasensitive detection of plasma amyloid-β as a biomarker for cognitively normal elderly individuals at risk of Alzheimer’s disease P Chatterjee, M Elmi, K Goozee, T Shah, HR Sohrabi, CB Dias, S Pedrini, ... Journal of Alzheimer's Disease 71 (3), 775-783, 2019 | 57 | 2019 |
| Plasma apolipoprotein J as a potential biomarker for Alzheimer's disease: Australian Imaging, Biomarkers and Lifestyle study of aging VB Gupta, JD Doecke, E Hone, S Pedrini, SM Laws, M Thambisetty, ... Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 3 (1), 18-26, 2016 | 57 | 2016 |
| Dietary composition modulates brain mass and solubilizable Aβ levels in a mouse model of aggressive Alzheimer's amyloid pathology S Pedrini, C Thomas, H Brautigam, J Schmeidler, L Ho, P Fraser, ... Molecular neurodegeneration 4, 1-10, 2009 | 56 | 2009 |
